Figure 11: HODOKORT study (http://hodokort-studie.hno.org/) [86]: The triple-blind, three-armed study with parallel group design encompasses two different high-dose corticosteroid therapies (intravenous prednisolone or oral dexamethasone application in an equivalent dosage) as well as a control group (middle line) receiving the internationally recommended lower-dose standard therapy. German Study Center for Otolaryngology, Head & Neck Surgery (DSZ-HNO) of the German Society of Otolaryngology, Head & Neck Surgery and the German Association of Otolaryngologists; Principle investigator (PI): Stefan K Plontke (Halle/Saale); Study Coordination: Coordination Center for Clinical Trials of Halle, University Medicine Halle, Martin Luther University Halle-Wittenberg; sponsored by the Research Funding Program on “Clinical Studies with high Relevance for Patient Care” in the context of health research program of the Federal Ministry for Research and Development (BMBF), Germany. The figure is taken from the study protocolŠ, courtesy of Martin Luther University Halle-Wittenberg.